Chronic and acute stress as predictors of relapse in primary breast cancer patients

Patient Education and Counseling

Volumn 37, Issue 3, 1999, Pages 265-272

  De Brabander, Bert ^a   Gerits, Pol ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Breast cancer; Relapse; Stress

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; NEUROCHEMISTRY; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STRESS; ACUTE DISEASE; ADAPTIVE BEHAVIOR; AGED; BELGIUM; BIOPSY; BREAST TUMOR; CANCER STAGING; CHRONIC DISEASE; FOLLOW UP; LIFE EVENT; LYMPHOCYTE COUNT; MENTAL STRESS; MIDDLE AGED; NATURAL KILLER CELL; PREDICTION AND FORECASTING; PROGNOSIS; RISK FACTOR; STATISTICAL MODEL; TUMOR RECURRENCE;

ACUTE DISEASE; ADAPTATION, PSYCHOLOGICAL; AGED; BELGIUM; BIOPSY; BREAST NEOPLASMS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KILLER CELLS, NATURAL; LIFE CHANGE EVENTS; LOGISTIC MODELS; LYMPHOCYTE COUNT; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 0033052295     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(99)00030-0     Document Type: Article

References (23)

1. Justice A. Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor. Psychol Bull. 98:1985;108-138.
2. Solcova I., Kebza V. Psychoneuroimmunology and coping with stress. Ceskoslovenska Psychol. 42:1988;32-41.
3. Amkraut A., Solomon G.F. Stress and murine sarcoma virus (maloney)-induced tumors. Can Res. 32:1972;1428-1433.
4. Sklar L.S., Anisman H. Transplanted carcinoma development and growth: effects of isolation, inescapable shock, and coping style. Soc Neurosc Abst. 4:1978;400.
5. Sklar L.S., Anisman H. Social stress influences tumor growth. Psychosom Med. 42:1980;347-365.
6. Sklar L.S., Anisman H. Stress and cancer. Psychol Bull. 89:1981;369-406.
7. DeBrabander B., D'Haeseleer F., DeBrabander M., Distelmans W., VanGinckel R., DeBrabander J. The protective effect of behavioral activation on the growth of a syngeneic tumor and mortality in socially stressed mice. Eur J Psych. 3:1989;238-244.
8. Basu S., Dasgupta P.S., Ray M.R., Lahiri T. Stimulation of NK activity in Ehrlich ascites carcinoma bearing mice following dopamine treatment. Biogenic Amines. 8:1992;191-197.
9. Gerits P. Psychoneuroimmunology and breast cancer: predictors of acute stress symptoms as a consequence of the diagnosis. Health psychology series. 3:1997;Rijksuniversiteit Leiden.
10. Glavin G.B. Stress and brain noradrenaline: a review. Neurosc Biobehav Rev. 9:1985;233-243.
11. Kaufman S., Friedman S. Dopamine B-hydroxylase. Pharmacol Rev. 17:1965;71-100.
12. Luteijn F., Hamel L.F., Bouwman T.K., Kok H.R. HSCL: Hopkins symptom check list: handleiding. 1984;Lisse, Swets and Zeitlinger.
13. Van Rooijen L. Enige gegevens over de vropsom-lijsten voor de bepaling van depressieve gevoelens. 1977;Vakgroep Sociale Psychologie, Vrije Universiteit, Amsterdam.
14. Scheinin M., Chang W., Jimerson D.C., Linnoila M. Measurement of 3-methoxy-4-hydroxyphenylglycol in human plasma with high performance liquid chromatography using electrochemical detection. Anal Biochem. 132:1983;165-170.
15. Blanco G., Alavaikko M., Ojala A., Collan Y., Heikinnen M., Hietanen T., Aine R., Taskinen P.J. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients. Anticancer Res. 4:1984;383-390.
16. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 244:1989;707-712.
17. Tsuckiya A., Katagata N., Kimijima I., Abe R. Immunohistochemical overexpression of CerbB-2 in the prognosis of breast cancer. Surgery Today. 23:1993;885-890.
18. Valugussa P., Bonadonna G., Veronesi U. Patterns of relapse and survival following radical mastectomy: analysis of 716 consecutive patients. Can. 41:1978;1170-1178.
19. Wiltschke C., Tyl E., Speiser P., Steininger A., Zeillinger R., Kury F., Czerwenka K., Kubista E., Preis P., Krainer M., Zielinske C.C. Increased natural killer cell activity correlates with low or negative expression of the Her-2/neu oncogene in patients with breast cancer. Can. 73:1994;135-139.
20. Fisher B., Osborne C.K., Margolese R., Bloomer W. Neoplasms of the breast. Holland J.F., Frei E., Bast R.C., Kufe D.W., Morton D.L., Weichselbaum R.R. Cancer medicine. 1993;1706-1774 Lea & Febiger, Philadelphia.
21. Dean C., Surtees P.G. Do psychological factors predict survival in breast cancer? J Psychosom Res. 33:1989;561-569.
22. Andersen B.L., Farrar W.B., GoldenKreutz D., Kutz L.A., MacCallum R., Courtney M.E., Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J Nat Can Inst. 90:1998;30-36.
23. Levy S.M., Herberman R.B., Lippman M., D'Angelo T., Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med. 14:1991;67-74.